Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr608 Inhibitors

Olr608 inhibitors represent a class of chemical compounds specifically designed to interact with the olfactory receptor 608 (Olr608), a protein that plays a significant role in olfactory signal transduction. Olr608 belongs to the extensive family of G-protein-coupled receptors (GPCRs), which are integral membrane proteins involved in a wide array of physiological processes by responding to extracellular signals and activating intracellular signal transduction pathways. In the context of olfaction, Olr608 is involved in detecting odorant molecules, which are then translated into neural signals, contributing to the sense of smell. The inhibitors of Olr608 are meticulously crafted molecules that can bind to this receptor, preventing its activation by natural odorants. This inhibition is achieved through various mechanisms, such as competitive inhibition, where the inhibitor mimics the structure of the natural ligand and competes for the binding site, or allosteric inhibition, where the inhibitor binds to a different site on the receptor, inducing a conformational change that reduces its activity.

The development of Olr608 inhibitors involves a deep understanding of the receptor's structure and function. Researchers utilize techniques such as X-ray crystallography and cryo-electron microscopy to elucidate the three-dimensional structure of Olr608, which provides insights into its binding sites and conformational dynamics. High-throughput screening methods and computational modeling are employed to identify and optimize potential inhibitors, focusing on their binding affinity, selectivity, and stability. The chemical diversity of Olr608 inhibitors is broad, encompassing small organic molecules, peptides, and synthetic analogs. Detailed studies on the binding kinetics and molecular interactions between Olr608 and its inhibitors reveal crucial information about the inhibition mechanism, guiding the design of more potent and selective compounds. Furthermore, understanding the pharmacokinetics and metabolic pathways of these inhibitors ensures their effective action within biological systems. Overall, Olr608 inhibitors are a fascinating subject of study within the field of chemical biology, providing valuable insights into the intricate mechanisms of olfactory signaling and receptor modulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Afatinib-d4

850140-72-6 (unlabeled)sc-481821
10 mg
$4665.00
(0)

Inhibits EGFR, HER2, and HER4, potentially disrupting proteins in these signaling pathways.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Inhibits MET, VEGFR, and RET, potentially disrupting proteins in multiple signaling pathways.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$141.00
$260.00
$278.00
$411.00
$12485.00
6
(1)

BRAF inhibitor, potentially interfering with proteins involved in the MAPK/ERK pathway.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Inhibits Bruton's tyrosine kinase, potentially impacting proteins in B-cell receptor signaling.

CAL-101

870281-82-6sc-364453
10 mg
$193.00
4
(1)

Inhibits PI3K delta, potentially hindering proteins involved in cell signaling and survival.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits BCR-ABL tyrosine kinase, potentially impeding proteins in leukemia-associated pathways.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Inhibits BCR-ABL and c-KIT tyrosine kinases, potentially altering proteins in associated signaling pathways.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits VEGF receptors, potentially impeding proteins involved in angiogenesis and tumor growth.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor, potentially impacting apoptosis-related proteins.